SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-15-003565
Filing Date
2015-08-12
Accepted
2015-08-12 16:03:30
Documents
11
Period of Report
2015-06-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm 10-Q 674215
2 ex10-4.htm EX-10.4 136354
3 ex31-1.htm EX-31.1 17001
4 ex31-2.htm EX-31.2 16960
5 ex32-1.htm EX-32.1 6061
  Complete submission text file 0001493152-15-003565.txt   5147631

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE immy-20150630.xml EX-101.INS 849494
7 XBRL SCHEMA FILE immy-20150630.xsd EX-101.SCH 64943
8 XBRL CALCULATION FILE immy-20150630_cal.xml EX-101.CAL 87428
9 XBRL DEFINITION FILE immy-20150630_def.xml EX-101.DEF 261743
10 XBRL LABEL FILE immy-20150630_lab.xml EX-101.LAB 479667
11 XBRL PRESENTATION FILE immy-20150630_pre.xml EX-101.PRE 360828
Mailing Address 12264 EL CAMINO REAL SUITE 350 SAN DIEGO CA 92130
Business Address 12264 EL CAMINO REAL SUITE 350 SAN DIEGO CA 92130 858-704-4042
Imprimis Pharmaceuticals, Inc. (Filer) CIK: 0001360214 (see all company filings)

IRS No.: 450567010 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35814 | Film No.: 151047017
SIC: 2834 Pharmaceutical Preparations